Follow
Camilla Pilati
Camilla Pilati
Université Paris Descartes
Verified email at inserm.fr
Title
Cited by
Cited by
Year
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
JC Nault, M Mallet, C Pilati, J Calderaro, P Bioulac-Sage, C Laurent, ...
Nature communications 4 (1), 2218, 2013
6782013
Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy
E Becht, A de Reyniès, NA Giraldo, C Pilati, B Buttard, L Lacroix, J Selves, ...
Clinical cancer research 22 (16), 4057-4066, 2016
5412016
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
S Rebouissou, M Amessou, G Couchy, K Poussin, S Imbeaud, C Pilati, ...
Nature 457 (7226), 200-204, 2009
5272009
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
JC Nault, S Datta, S Imbeaud, A Franconi, M Mallet, G Couchy, E Letouzé, ...
Nature genetics 47 (10), 1187-1193, 2015
4922015
Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation
JC Nault, G Couchy, C Balabaud, G Morcrette, S Caruso, JF Blanc, ...
Gastroenterology 152 (4), 880-894. e6, 2017
3562017
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
C Pilati, M Amessou, MP Bihl, C Balabaud, JT Van Nhieu, V Paradis, ...
Journal of Experimental Medicine 208 (7), 1359-1366, 2011
2712011
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation
C Pilati, E Letouzé, JC Nault, S Imbeaud, A Boulai, J Calderaro, ...
Cancer cell 25 (4), 428-441, 2014
2652014
Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression
S Rebouissou, A Franconi, J Calderaro, E Letouzé, S Imbeaud, C Pilati, ...
Hepatology 64 (6), 2047-2061, 2016
2542016
Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas
C Pilati, J Shinde, LB Alexandrov, G Assié, T André, Z Hélias‐Rodzewicz, ...
The Journal of pathology 242 (1), 10-15, 2017
1492017
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation
JC Nault, M Fabre, G Couchy, C Pilati, E Jeannot, JT Van Nhieu, ...
Journal of hepatology 56 (1), 184-191, 2012
1372012
A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy
Z Saridaki, JB Weidhaas, HJ Lenz, P Laurent-Puig, B Jacobs, ...
Clinical Cancer Research 20 (17), 4499-4510, 2014
732014
CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification
C Pilati, J Taieb, R Balogoun, L Marisa, A De Reyniès, P Laurent-Puig
Annals of Oncology 28 (5), 1032-1035, 2017
692017
STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model
L Couronné, L Scourzic, C Pilati, V Della Valle, Y Duffourd, E Solary, ...
Haematologica 98 (11), 1748, 2013
662013
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis
RT Lawlor, N Veronese, A Pea, A Nottegar, L Smith, C Pilati, J Demurtas, ...
BMC cancer 19, 1-7, 2019
572019
Mutations leading to constitutive active gp130/JAK1/STAT3 pathway
C Pilati, J Zucman-Rossi
Cytokine & Growth Factor Reviews 26 (5), 499-506, 2015
572015
Wild-type AAV insertions in hepatocellular carcinoma do not inform debate over genotoxicity risk of vectorized AAV
JC Nault, I Mami, T La Bella, S Datta, S Imbeaud, A Franconi, M Mallet, ...
Molecular Therapy 24 (4), 660-661, 2016
502016
PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications
C Luchini, J Cros, A Pea, C Pilati, N Veronese, B Rusev, P Capelli, ...
Human pathology 81, 157-165, 2018
462018
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma
K Poussin, C Pilati, G Couchy, J Calderaro, P Bioulac-Sage, Y Bacq, ...
Oncoimmunology 2 (12), e27090, 2013
432013
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis
C Luchini, N Veronese, A Nottegar, M Cheng, T Kaneko, C Pilati, F Tabbò, ...
Virchows Archiv 472, 939-947, 2018
352018
Clinical utility of colon cancer molecular subtypes: Validation of two main colorectal molecular classifications on the PETACC-8 phase III trial cohort.
L Marisa, M Ayadi, R Balogoun, C Pilati, K Le Malicot, C Lepage, JF Emile, ...
Journal of Clinical Oncology 35 (15_suppl), 3509-3509, 2017
342017
The system can't perform the operation now. Try again later.
Articles 1–20